The use of complementary and alternative medicine by patients with chronic hepatitis C

Complementary Therapies in Clinical Practice

Volumn 16, Issue 3, 2010, Pages 124-131

  Richmond, Jacqueline A ^a   Bailey, Donald E ^b   Patel, Keyur ^a   Jezsik, Janet A ^c   Muir, Andrew ^a   Lin, Jr Rung ^d   Chow, Shein Chung ^d   Uzarski, Diane ^a   McHutchison, John G ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative health care; Attitudes; Patient support; Viral hepatitis

Indexed keywords

ANTIVIRUS AGENT; VITAMIN;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; EDUCATIONAL STATUS; FEMALE; HEALTH CARE SURVEY; HEALTH STATUS; HEPATITIS C; HUMAN; INTERVIEW; LIVER DISEASE; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PHYTOTHERAPY; QUESTIONNAIRE; SPIRITUAL HEALING; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADULT; AMBULATORY CARE FACILITIES; ANTIVIRAL AGENTS; COMPLEMENTARY THERAPIES; EDUCATIONAL STATUS; FAITH HEALING; FEMALE; HEALTH CARE SURVEYS; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; INTERVIEWS AS TOPIC; LIVER DISEASES; MALE; MIDDLE AGED; PHYTOTHERAPY; QUESTIONNAIRES; UNITED STATES; VITAMINS;

EID: 77954457719     PISSN: 17443881     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctcp.2009.10.004     Document Type: Article

References (30)

1. National Center for Complementary and Alternative Medicine. Bethesda: National Institute of Health. Available from: [accessed 15.06.09]. http://nccam.nih.gov.
2. Barnes P.M., Powell-Griner E., McFann K., Nahin R.L. Complementary and alternative medicine use among adults: United States, 2002. CDC advance data from vital and health statistics 2004, vol. 343. National Center for Health Statistics, Hyattsville, Maryland, pp. 1-19.
3. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow up national survey. JAMA 1998, 280:1569-1575.
4. Saydah S.H., Eberhardt M.S. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med 2006, 12:805-812.
5. Astin J.A. Why patients use alternative medicine - results of a national study. JAMA 1998, 279:1548-1553.
6. Rustgi V.K. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007, 42:513-521.
7. World Health Organisation and Viral Hepatitis Prevention Board Global surveillance and control of hepatitis C. J Viral Hepat 1999, 6:35-47.
8. Foster G.R., Goldin R.D., Thomas H.C. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998, 27:209-212.
9. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358:958-965.
10. Fried M.W., Shiffman M., Reddy K.R., Smith C., Marinos G., Goncales F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975-982.
11. Modi A.A., Wright E.C., Seeff L.B. Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review. Antivir Ther 2007, 12:285-295.
12. Strader D.B., Bacon B.R., Lindsay K.L., La Brecque D.R., Morgan T., Wright E.C., et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002, 97:2391-2397.
13. Siddiqui U., Weinshel E.H., Bini E.J. Prevalence and predictors of herbal medication use in veterans with chronic hepatitis C. J Clin Gastroenterol 2004, 38:605-610.
14. White C.P., Hirsch G., Patel S., Adams F., Peltekian K.M. Complementary and alternative medicine use by patients chronically infected with hepatitis C. Can J Gastroenterol 2007, 21:589-595.
15. Bruguera M., Barrera J.M., Ampurdanes S., Forns X., Sanchez Tapias J.M. Use of complementary and alternative medicine in patients with chronic hepatitis C. Medicinia Clinica 2004, 123:676. [Abstract].
16. Seeff L.B., Curto T.M., Szabo G., Everson G.T., Bonkovsky H.L., Dienstag J.L., et al. Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology 2008, 47:605-612.
17. Robinson A., McGrail M.R. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004, 12:90-98.
18. Deng G.E., Cassileth B.R., Cohen L., Gubil J., Johnstone P.A.S., Kumar N., et al. Integrative oncology practice guidelines. J Soc for Integr Oncol 2007, 5(2):65-84.
19. Cupp M.J. Herbal remedies: adverse effects and drug interactions. Am Fam Phys 1999, 59:1239-1244.
20. Seeff L.B., Lindsay K.L., Bacon B.R., Kresina T.F., Hoofnagle J.H. Complementary and alternative medicine in chronic liver disease. Hepatology 2001, 34:595-603.
21. Oldendick R., Coker A.L., Wieldand D., Raymond J.I., Probst J.C., Schell B.J., et al. Population-based survey of complementary and alternative medicine usage, patient satisfaction and physician involvement. South Med J 2000, 93:375-381.
22. Hilsden R.J., Verhoef M.J., Best A., Pocobelli G. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003, 98:1563-1568.
23. Siapush M. Why do people favour alternative medicine?. Aust N Z J Public Health 1999, 23:266-271.
24. Satarino W., Ragheb Dupis M. Comorbidity in older women with breast cancer: an epidemiological approach. Eval Program Plan 1989, 12:329-336.
25. Kilpatrick F.P., Cantril H. Self-anchoring scaling: a measure of individual's unique reality worlds. J Individual Psychol 1960, 16:158-173.
26. Sandelowski M. Whatever happened to qualitative description?. Res Nurs Health 2000, 23:334-340.
27. Strauss A., Corbin J. Basics of qualitative research: grounded theory procedures and techniques 1998, Sage, Newbury Park. 2nd ed.
28. Verhoef M.J., Rapchuk I., Liew T., Weir V., Hilsden R.J. Complementary practitioners' views of treatment for inflammatory bowel disease. Can J Gastroenterol 2002, 26:95-100.
29. Stickle F., Schuppan D. Herbal medicine in the treatment of liver disease. Dig Liv Dis 2007, 39:293-304.
30. Verma S., Thuluvath P.J. Complementary and alternative medicine in hepatology: review of the evidence of efficacy. Gastroenterol Hepatol 2007, 5:408-416.